EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Obesity and Female Reproductive Health; Is There a Role for Glucagon‐Like Peptide‐1 Receptor Agonists?

Rachel Roberts iD, Anurag Markande, Lorraine Kasaven, Sarah Chieveley Williams, Raef Faris, Timothy Bracewell-Milnes, Yau Thum, James Nicopoullos, Benjamin P Jones

Obesity Reviews · 2026

DOI: 10.1111/obr.70015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Obesity Reviews, 2026. Verfasst von Rachel Roberts und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wolfson Fertility Clinic, Hammersmith Hospital, London, United Kingdom. Hauptthemen laut MEDLINE: Obesity, Glucagon-Like Peptide-1 Receptor Agonists, Reproductive Health, Infertility, Female. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 117 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Women with a raised body mass index are likely to take longer to conceive and have poorer outcomes from fertility treatment. Furthermore, fertility clinics commonly require women to have body mass index < 30 kg/m 2 prior to treatment. Consequently, many women face the challenge of needing to lose weight to improve their chances of conception or to become eligible for fertility treatment. For these women, there is an additional pressure to lose weight quickly due to the diminishment in reproductive potential with advancing age. Synthetic glucagon‐like peptide‐1 receptor agonists have been shown to cause rapid weight loss in individuals with obesity, as well as reversing some of the metabolic dysfunction associated with obesity and polycystic ovarian syndrome. The potential effect of preconception glucagon‐like peptide‐1 receptor agonist therapy to increase the chance of pregnancy in women with obesity is an emerging area of research. If this treatment proves to be safe and effective, it could provide significant benefits for many overweight women facing infertility. This article summarizes our understanding of the effect of obesity and polycystic ovarian syndrome on fertility and the success of assisted reproductive techniques. It also describes the traditional treatments for obesity, the pharmacology of glucagon‐like peptide‐1 receptor agonists, and the evidence for glucagon‐like peptide‐1 receptor agonists in improving fertility and pregnancy outcomes in overweight women, as well as the potential safety and ethical issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityGlucagon-Like Peptide-1 Receptor AgonistsReproductive HealthInfertility, FemaleHumansFemalePregnancyPolycystic Ovary SyndromeReproductive Techniques, Assisted

Stichwörter der Autor:innen

GLP‐1 receptor analoguesPCOSinfertilityobesitysemaglutide

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Wolfson Fertility Clinic, Hammersmith Hospital, London, United Kingdom.
  • Chelsea and Westminster Hospital, London, United Kingdom.
  • Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom.
  • Lister Fertility Clinic, The Lister Hospital, London, United Kingdom.

ORCID-Profile: Rachel Roberts

Zitieren

APA

Roberts, R., Markande, A., Kasaven, L., Williams, S. C., Faris, R., Bracewell-Milnes, T., Thum, Y., Nicopoullos, J., & Jones, B. P. (2026). Obesity and Female Reproductive Health; Is There a Role for Glucagon‐Like Peptide‐1 Receptor Agonists?. Obesity Reviews. https://doi.org/10.1111/obr.70015

Vancouver

Roberts R, Markande A, Kasaven L, Williams SC, Faris R, Bracewell-Milnes T, et al. Obesity and Female Reproductive Health; Is There a Role for Glucagon‐Like Peptide‐1 Receptor Agonists?. Obesity Reviews. 2026. doi:10.1111/obr.70015

BibTeX
@article{Roberts2026,
  author = {Roberts, Rachel and Markande, Anurag and Kasaven, Lorraine and Williams, Sarah Chieveley and Faris, Raef and Bracewell-Milnes, Timothy and Thum, Yau and Nicopoullos, James and Jones, Benjamin P},
  title = {Obesity and Female Reproductive Health; Is There a Role for Glucagon‐Like Peptide‐1 Receptor Agonists?},
  journal = {Obesity Reviews},
  year = {2026},
  doi = {10.1111/obr.70015}
}
Kostenlos starten →